))
Key Pharmaceutical Regulation Issues for the New Administration
Manage episode 459587083 series 3622804
Вміст надано Michael Levin-Epstein and FDA Watch. Весь вміст подкастів, включаючи епізоди, графіку та описи подкастів, завантажується та надається безпосередньо компанією Michael Levin-Epstein and FDA Watch або його партнером по платформі подкастів. Якщо ви вважаєте, що хтось використовує ваш захищений авторським правом твір без вашого дозволу, ви можете виконати процедуру, описану тут https://uk.player.fm/legal.
In our first episode, Shelly and Wayne chat with Nikki Reeves, Partner in the FDA & Life Sciences practice at King & Spalding, and Brian Malkin, Associate General Counsel for Regulatory Law at Teva Pharmaceuticals. You’ll hear their thoughts on the top priorities in pharmaceutical regulation for the next FDA commissioner and their insights on AI policy, patient voices, and other front-burner issues.
In our headlines segment, Shelly and Wayne delve into these major developments:
Pharma: More than 200,000 Prescriptions for Wegovy Filled
Devices: FDA Announces Communication Pilot on Recalls
Food: Fruits & Vegetables: Are They Really Safe?
Cosmetics: FDA Issue Final Rule on Color Additive Certification Fees
In our Resource Links segment, we listed key documents in our fore core areas. To view these links, subscribe, or find out more information about our podcast, visit FDAWatch.net.
Want to be a sponsor, marketing partner, or guest, or provide feedback on the podcast? Email us at info@FDAWatch.net.
Music by Dvir Silver from Pixabay.
4 епізоди
Поширити
